In today's rapidly evolving healthcare landscape, health technology assessment (HTA) agencies face a difficult challenge: keeping up with the fast-paced development of innovative technologies.
This course is available on the Executive MSc in Health Economics, Outcomes and Management in Clinical Sciences and Executive MSc in Health Economics, Policy and Management. This course is not ...
This course is compulsory on the Executive MSc in Healthcare Decision-Making, in collaboration with NICE. This course is not available as an outside option. Health Technology Assessment a ...
This course is for statisticians, health economists, and decision modellers who are interested in understanding and applying the latest evidence synthesis and population adjustment methodologies in ...
Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health ...
Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative treatments to market more quickly. However, they also require developers to ...
With degrees in mathematical philosophy (University of Cambridge), demography (LSE) and health economics (University of York), Mike Chambers is currently founder and director of MC Healthcare ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する